PurCell Bio has filed a notice of an exempt offering of securities to raise $1,300,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, PurCell Bio is raising up to $1,300,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Elizabeth Corbin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About PurCell Bio
PurCell Bio is a cell culture research company located in Bozeman, MT. We have developed a line of cell culture media and media supplements that surpass the growth performance of serum and eliminate the major problems associated with serum use: batch to batch variability, contamination concerns, and high cost. Our vision is that PurCells products will initiate an industry-wide exodus from animal-based products to chemically-defined alternatives. This shift will remove a tremendous barrier for cellular-based therapies entering clinical trials and also facilitate more effective research around the world.
To learn more about PurCell Bio, visit http://purcell-bio.com/
Contact:
Elizabeth Corbin, Chief Executive Officer
406-206-3004
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.